

Early insights into emerging data, innovations, and breakthroughs shaping the future of healthcare.
Welcome to THE EDGE
Interviews
Conducted by Julianne Dunphy PhD, EVP Medical Strategy, RevHealth
US WorldMeds: rare pediatric oncology
BioAtla: new target, novel ADCs
Want more?
Download a copy of "Hidden Gems From ASCO 2025 That Signal the Future of Oncology"
Articles


ASCO 2025: Preparing for the tumor’s next move
Explore key insights from ASCO 2025 on how adaptive cancer therapies are reshaping tumor evolution—and what it means for oncology marketers. View Article
What I Took Away From My First ASCO—and Why It Matters for Pharma Brand Builders
RevHealth CCO William Martino shares takeaways from ASCO 2025, highlighting strategic insights that can shape brand strategy and oncology ... View Article
ASCO 2025: Data Differentiation & the Future of Oncology Education
Explore how nuanced clinical data presentation at ASCO 2025 will shape oncology education strategies and create competitive advantage for ... View Article
Looking Ahead to ASCO 2025: What Oncology Innovation Means for Pharma Brands
Get ahead of oncology innovation trends revealed at ASCO 2025 and what they mean for pharmaceutical marketers building future-ready brands. View Article
Undercurrents at ASCO: The Innovation that May Hide and Why It Matters
Ahead of ASCO 2025, a RevHealth medical strategist shares key under-the-radar innovations that could shape the future of oncology brand strategy. View ArticleInsights From The Edge

RevHealth doesn't just attend leading healthcare conferences—we decode them. We distill the most critical moments and overlooked insights—turning information into inspiration, and data into direction.
This isn't a recap. It's a strategic lens on innovations, trends, and possibilities shaping the future of care. Because insight alone isn't enough. It's how you act on it that creates a real advantage.